US and China clash over fentanyl and tariffs at global drugs meeting, via Reuters; The Trump administration has told Beijing it expects to reimpose that levy under a different law
- "The United States and China traded barbs at a U.N. drugs meeting on Monday, with Washington accusing Beijing of failing to stop sales of precursor chemicals for fentanyl and China dismissing the allegation as false while calling the U.S. irresponsible."
- The U.S. Supreme Court last month invalidated a 10% fentanyl-related tariff Trump had imposed on China and others under an emergency statute. The Trump administration has told Beijing it expects to reimpose that levy under a different law, a U.S. official said.
Context
The ongoing U.S.-China tensions regarding fentanyl and tariffs signal a potential escalation in trade conflicts, particularly as the Trump administration seeks to reinstate tariffs under a different legal framework. This could heighten volatility in financial markets, impacting asset classes like equities and commodities, and may further strain USD and CNY exchange rates. Traders should watch for market reactions in risk-sensitive assets, particularly in light of any retaliatory measures from China.
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard#UNITED STATES#USD#EUR#CHINA#JAPAN#JPY#UNITED KINGDOM#GBP#ASIA#EUROPE#GEOPOLITICAL#IMPORTANT#FOREX#EQUITIES#ENERGY#METALS#EU SESSION#US SESSION#DOW JONES INDUSTRIAL AVERAGE#WTI#COMMODITIES#GOLD#CHEMICALS#METALS & MINING#MATERIALS (GROUP)#S&P 500 INDEX#NASDAQ 100 INDEX#BRENT CRUDE#DXY#TRUMP#TARIFF#TRADE